Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cicaplast Balm B5+ versus standard moisturizer for skin barrier repair during oral isotretinoin treatment in acne
ChiCTR2400094437Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Cicaplast Baume B5+ and isotretinoin in acne vulgaris (2 arms), sponsored by Renji Hospital. Primary endpoint: Transepidermal water loss at Day 56. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
Cicaplast Baume B5+isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ChiCTR2400094437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094437.